Visum

Visum Pharmaceutical Co., Ltd. was established in June 2010, with its headquarters located in the High-tech Development Zone of Haikou City. It currently has 2 manufacturing centers, 2 research and development centers, and 1 marketing center. The company has successfully passed FDA's GMP inspection 4 times and NMPA's quality inspection 3 times. Currently, 5 products have been launched in the Chinese or American markets, with an annual export volume of controlled-release formulations exceeding 400 million tablets. Visum is a comprehensive pharmaceutical enterprise integrating the research, production, export, and sales of high-end oral solid dosage forms. It is committed to building a high-quality one-stop international CDMO platform, providing customers with various forms of customized services, and assisting domestic and foreign pharmaceutical enterprises in expanding into international markets such as China, the United States, the European Union, and WHO.